Panacea Innovation Ltd - 31 Mar 2026 SCHEDULE 13D/A Report for Connect Biopharma Holdings Limited Ordinary Shares (CNTB)
- Filing Manager
- Panacea Innovation Ltd
- Reporting Manager
- Panacea Innovation Limited
- Symbol
- CNTB
- Shares outstanding
- 62,075,472 shares
- Disclosed Ownership
- 13,160,000 shares
- Ownership
- 21%
- Form type
- SCHEDULE 13D/A
- Filing time
- 01 Apr 2026, 16:30:02 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 26 Nov 2025
- SEC
- View on sec.gov
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Panacea Innovation Limited | 21% | 13,160,000 | 0 | 13,160,000 | /s/ James Huang | James Huang, Founding Managing Partner | 0002010692 |
| Panacea Venture Healthcare Fund II, L.P. | 21% | 13,160,000 | 0 | 13,160,000 | By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang | James Huang, Founding Managing Partner | 0001869939 |
| Panacea Venture Healthcare Fund II GP Company, Ltd. | 21% | 13,160,000 | 0 | 13,160,000 | /s/ James Huang | James Huang, Founding Managing Partner | |
| James Huang | 21% | 13,160,000 | 0 | 13,160,000 | /s/ James Huang | James Huang | 0001573160 |